Risk assessment – Pharma GMP

How to Justify Batch Release Decisions When Deviations Occur

digi — Wed, 26 Nov 2025 02:39:04 +0000

How to Justify Batch Release Decisions When Deviations Occur Step-by-Step Guide to Justifying Batch Release Decisions When Deviations Occur In pharmaceutical manufacturing, GMP expectations for batch release impose rigorous standards to ensure product quality, safety, and efficacy. Despite robust manufacturing controls, deviations from established processes inevitably occur. Deciding whether a batch with deviations can be...

Cross Contamination Risk Assessment: Practical Tools and Examples

digi — Wed, 26 Nov 2025 01:21:04 +0000

Cross Contamination Risk Assessment: Practical Tools and Examples Cross Contamination Risk Assessment: Practical Tools and Examples for Pharma Cross contamination prevention in manufacturing is a critical focus area within pharmaceutical Good Manufacturing Practice (GMP). Effective management of cross contamination risks ensures product quality, patient safety, and regulatory compliance. This step-by-step tutorial outlines practical risk assessment...

Risk Assessment Template for High Potency Product Manufacturing

digi — Wed, 26 Nov 2025 01:00:04 +0000

Risk Assessment Template for High Potency Product Manufacturing Step-by-Step Guide to Implementing GMP Controls for High Potency Products via Effective Risk Assessment Manufacturing high potency pharmaceutical products demands stringent GMP controls for high potency products to ensure product quality, operator safety, and environmental containment. The unique challenges posed by these substances necessitate a robust and...

SOP for Quality Risk Management in Line with ICH Q9

digi — Wed, 26 Nov 2025 00:27:04 +0000

SOP for Quality Risk Management in Line with ICH Q9 Step-by-Step Tutorial Guide: Developing a Quality Risk Management SOP Aligned with ICH Q9 Effective quality risk management (QRM) is fundamental to maintaining robust pharmaceutical quality systems compliant with regulatory requirements in the US, UK, and EU. This step-by-step tutorial provides a comprehensive guide to drafting...

Managing Extended Hold Times: Risk Assessment and Stability Data

digi — Tue, 25 Nov 2025 17:36:04 +0000

Managing Extended Hold Times: Risk Assessment and Stability Data Effective Management of Extended Hold Times: A Step-by-Step Guide to Risk Assessment and Stability Data for Bulk Products and Intermediates In pharmaceutical manufacturing, managing hold times between processing steps for bulk products and intermediates is a critical aspect to ensure product quality, integrity, and compliance with...

Risk Assessment for Rework and Reprocessing Decisions

digi — Tue, 25 Nov 2025 17:18:04 +0000

Risk Assessment for Rework and Reprocessing Decisions: A GMP Step-by-Step Tutorial Step-by-Step Guide to Risk Assessment for Rework and Reprocessing of Batches GMP In pharmaceutical manufacturing, the rework and reprocessing of batches GMP pose significant challenges for both operational excellence and compliance. Manufacturers must conduct thorough risk assessment to ensure patient safety, regulatory conformity, and...

Risk Assessment: When Is Dedicated Equipment Required?

digi — Tue, 25 Nov 2025 01:30:42 +0000

Risk Assessment: When Is Dedicated Equipment Required? Risk Assessment Guide for Determining When Dedicated Equipment is Required in Pharmaceutical Manufacturing Implementing GMP requirements for dedicated equipment is a critical consideration for pharmaceutical manufacturers aiming to comply with regulatory expectations while ensuring product quality and patient safety. This step-by-step tutorial provides a practical framework for conducting...

GMP Training Needs Analysis: Identifying Gaps Before Inspectors Do

digi — Sat, 15 Nov 2025 11:59:47 +0000

GMP Training Needs Analysis: Identifying Gaps Before Inspectors Do Comprehensive Guide to Conducting a Training Needs Analysis GMP for Pharma Professionals Good Manufacturing Practice (GMP) compliance relies heavily on the competency and proficiency of personnel involved in manufacturing, quality control, and related pharmaceutical processes. A robust training needs analysis GMP is critical to identifying gaps...

FDA Data Integrity Inspections: How to Defend Your Controls and Rationale

digi — Sat, 15 Nov 2025 08:14:47 +0000

FDA Data Integrity Inspections: How to Defend Your Controls and Rationale Practical Guide to Meeting FDA Data Integrity Expectations During Inspections Data integrity remains a cornerstone of regulatory compliance within pharmaceutical manufacturing. The FDA data integrity expectations are rigorous and enforcing, particularly when it comes to data integrity and compliance with drug CGMP. Navigating FDA...

Data Integrity Risk Assessment: Prioritising Where Controls Matter Most

digi — Sat, 15 Nov 2025 07:41:47 +0000

Data Integrity Risk Assessment: Prioritising Where Controls Matter Most Step-By-Step Guide to Conducting a Data Integrity Risk Assessment in Pharmaceutical Environments Within pharmaceutical manufacturing and quality control, maintaining pharma data integrity is paramount to ensuring patient safety, robust regulatory compliance, and product quality. Regulatory agencies including the US Food and Drug Administration (FDA), the European...